# Pedevco Corp: overview PED · NYSE · CIK 1141197 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ped.md) · [Financials](/companies/ped/financials.md) · [Filings](/companies/ped/filings.md) · [Insiders](/companies/ped/insiders.md) Latest reported revenue: [$46.1m](/filings/0001654954-26-007591.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001654954-26-007591). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [9.1](/filings/0001654954-25-013092.md) | [10.6 d](/filings/0001654954-26-003098.md) | [8.7](/filings/0001654954-26-004891.md) | [7.0](/filings/0001654954-26-007591.md) | [7.0](/filings/0001654954-25-013092.md) | [23.1 d](/filings/0001654954-26-003098.md) | [40.2](/filings/0001654954-26-004891.md) | [46.1](/filings/0001654954-26-007591.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [31.3%](/filings/0001654954-25-013092.md) | [(12.8%) d](/filings/0001654954-26-003098.md) | [1.7%](/filings/0001654954-26-004891.md) | [(32.2%)](/filings/0001654954-26-007591.md) | [(12.0%)](/filings/0001654954-25-013092.md) | [(21.3%) d](/filings/0001654954-26-003098.md) | [16.7%](/filings/0001654954-26-004891.md) | [33.3%](/filings/0001654954-26-007591.md) | | Net margin | % | [32.2%](/filings/0001654954-25-013092.md) | [56.0% d](/filings/0001654954-26-003098.md) | [1.6%](/filings/0001654954-26-007591.md) | [(24.0%)](/filings/0001654954-26-007591.md) | [(4.7%)](/filings/0001654954-25-013092.md) | [(36.8%) d](/filings/0001654954-26-003098.md) | [(63.7%)](/filings/0001654954-26-007591.md) | [37.9%](/filings/0001654954-26-007591.md) | | Diluted EPS | $ per share | [0.03](/filings/0001654954-25-013092.md) | not reported | [0.03](/filings/0001654954-26-004891.md) | [(0.37)](/filings/0001654954-26-007591.md) | [0.00](/filings/0001654954-25-013092.md) | not reported | [(3.28)](/filings/0001654954-26-004891.md) | [1.31](/filings/0001654954-26-007591.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [15.9](/filings/0001654954-23-003759.md) | [30.0](/filings/0001654954-24-003240.md) | [30.8](/filings/0001654954-25-012381.md) | [39.6](/filings/0001654954-26-003098.md) | [45.8](/filings/0001654954-26-003098.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(11.8%)](/filings/0001654954-23-003759.md) | [8.8%](/filings/0001654954-24-003240.md) | [4.0%](/filings/0001654954-25-012381.md) | [11.9%](/filings/0001654954-26-003098.md) | [(17.2%)](/filings/0001654954-26-003098.md) | | Net margin | % | [(8.2%)](/filings/0001654954-23-003759.md) | [9.5%](/filings/0001654954-24-003240.md) | [5.5%](/filings/0001654954-25-012381.md) | [31.1%](/filings/0001654954-26-003098.md) | [(22.6%)](/filings/0001654954-26-003098.md) | | Diluted EPS | $ per share | [(0.02)](/filings/0001654954-23-003759.md) | [0.03](/filings/0001654954-24-003240.md) | [0.02](/filings/0001654954-25-012381.md) | [2.76](/filings/0001654954-26-003098.md) | [(2.25)](/filings/0001654954-26-003098.md) | | Free cash flow | $m | not reported | [16.0](/filings/0001654954-24-003240.md) | [23.4](/filings/0001654954-25-012381.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ped/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Juniper Capital Advisors, L.P.](/funds/2011609.md) | 2026-06-30 | $92.4m | 6,861,564 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.5m | 187,404 | | Added +128,977 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.7m | 123,311 | | New +123,311 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $1.6m | 115,818 | | Added +115,442 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $500.1k | 37,158 | | Added +22,263 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $273.9k | 20,349 | | New +20,349 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $266.4k | 19,791 | | Added +12,886 | | [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $172.2k | 12,796 | | New +12,796 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $164.5k | 12,221 | | Added +635 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $152.4k | 11,325 | | New +11,325 | ## Recent filings [All 934 filings](/companies/ped/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-13 | 12:11 ET | [SCHEDULE 13D/A](/filings/0001654954-26-008906.md) | Ownership report, active investor, amended | 0001654954-26-008906 | | 2026-09-21 | 12:16 ET | [8-K](/filings/0001654954-26-008485.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-26-008485 | | 2026-09-16 | 12:01 ET | [8-K](/filings/0001654954-26-008401.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-008401 | | 2026-08-28 | 21:02 ET | [8-K](/filings/0001654954-26-007962.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-26-007962 | | 2026-08-25 | 20:05 ET | [8-K/A](/filings/0001654954-26-007860.md) | 9.01 Financial statements and exhibits | 0001654954-26-007860 | | 2026-08-13 | 20:14 ET | [10-Q](/filings/0001654954-26-007591.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007591 | | 2026-08-13 | 20:06 ET | [8-K](/filings/0001654954-26-007586.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-007586 | | 2026-07-24 | 21:30 ET | [8-K](/filings/0001654954-26-006883.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-26-006883 | | 2026-07-17 | 21:30 ET | [8-K](/filings/0001654954-26-006724.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-26-006724 | | 2026-07-15 | 20:30 ET | [DEF 14A](/filings/0001654954-26-006667.md) | Proxy statement, period 2026-07-09 | 0001654954-26-006667 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001654954-26-003098.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/2585f107-cbb8-4fc9-8544-4dfce01a4fe2) ## About the filer - CIK: 1141197 - Tickers: PED - Exchange: NYSE - SIC code: 1311 Crude Petroleum & Natural Gas - State of incorporation: TX - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.